Recruiting

Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)

Sponsor:

Travera Inc

Code:

NCT05461430

Conditions

Pleural Effusion, Malignant

Ascites, Malignant

Carcinoma

Carcinoma, Hepatocellular

Carcinoma, Renal Cell

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information